Cargando…
Impact of delayed initiation of erythropoietin in critically ill patients
BACKGROUND: The purpose of this study was to evaluate the impact of recombinant human erythropoietin (rHuEPO) use for anemia of critical illness at a practice site where delayed initiation is common. METHODS: Retrospective medical record review involving patients treated with rHuEPO for anemia of cr...
Autores principales: | Duby, Jeremiah J, Erstad, Brian L, Abarca, Jacob, Camamo, James M, Huckleberry, Yvonne, Bramblett, Stuart N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077862/ https://www.ncbi.nlm.nih.gov/pubmed/17916251 http://dx.doi.org/10.1186/1471-2326-7-1 |
Ejemplares similares
-
Drug dosing in the critically ill obese patient—a focus on sedation, analgesia, and delirium
por: Erstad, Brian L., et al.
Publicado: (2020) -
Erythropoietin and renin as biological markers in critically ill patients
por: Tamion, Fabienne, et al.
Publicado: (2004) -
Erythropoietin in the critically ill – is it more than just blood?
por: Corwin, Howard L
Publicado: (2004) -
Erythropoietin mimics the acute phase response in critical illness
por: Elliot, John Michael, et al.
Publicado: (2003) -
Recombinant human erythropoietin therapy in critically ill patients
por: Georgopoulos, D, et al.
Publicado: (2005)